By 2027, the Enteric Disease Testing Market will be significantly dominated by molecular diagnostic testing, according to testing method. This can be attributed to the quick advancement of real-time, high throughput PCR technologies for the identification of bacterial and viral enteric illnesses. Similar to how the strong demand for genomic and genetic data has prompted the proliferation of molecular diagnostic alternatives throughout the healthcare spectrum, this testing approach will likely continue to grow in the coming years. Typhoid fever is becoming more common in the United States, and it is typically brought on by travel abroad. As a result, the market for enteric illness testing in North America is expected to experience significant growth by 2028. The typhoid Salmonella virus has infected nearly 500 people in the nation.
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2022/11/enteric-disease-testing-market-size.html
